Skip to search formSkip to main contentSkip to account menu

Aggrastat

Known as: Merck Frosst brand of tirofiban hydrochloride monohydrate, Agrastat, Cahill May Roberts brand of tirofiban hydrochloride monohydrate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
This study aims to investigate the short-term efficacy and safety of intracoronary tirofiban administration during emergency… 
2013
2013
Objective To evaluate the effects of intracoronary tirofiban during emergency intervention in patients with acute coronary… 
2012
2012
Background:­ In this article, we aimed to investigate the effects of antithrombotic agents, including acetyl salicylic acid (ASA… 
2011
2011
Objective:To compare the efficacy and safety of intracoronary tirofiban versus urokinase during primary PCI in patients with… 
2010
2010
A 27 year-old man presented with chest pain lasting for fourteen-hour duration. The patient had electrocardiographic evidence of… 
2009
2009
AIM To evaluate the efficacy and safety of intracoronary tirofiban on TIMI flow in acute coronary syndrome (ACS) with noreflow… 
2009
2009
Objective To observe the cardiac events and bleeding complication,evaluate the safety and efficacy of domestic Tirofiban… 
2007
2007
Objective To study the effect and safety of tirofiban hydrochlorid in patients with acute coronary syndromes (ACS) during their… 
Review
2001
Review
2001
Therapy involving the use of anti-GPIIb-IIIa inhibitors has progressively evolved in recent years for patients undergoing…